EP4203919
Samsetning sem byggist á lípíði til gjafar um munn á bradýkínín-B2 viðtaka-mótlyfjum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.8.2022EP published:
31.1.2024EP application number:
22760986.4
EP translation filed:
22.4.2024Grant published:
15.5.2024EPO information:
European Patent Register
Max expiry date:
4.8.2042Expiry date:
4.8.2026Next due date:
31.8.2026
Title in English:
LIPID-BASED COMPOSITION FOR ORAL ADMINISTRATION OF BRADYKININ B2-RECEPTOR ANTAGONISTSLanguage of the patent:
English
Timeline
Today
5.8.2022EP application
31.1.2024EP Publication
22.4.2024Translation submitted
15.5.2024Registration published
4.8.2026Expires
Owner
Name:
Pharvaris GmbHAddress:
Grafenauweg 8, 6300 Zug, CH
Inventor
Name:
GIBSON, ChristophAddress:
6300 Zug, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
21189990Date:
5.8.2021Country:
EP
Classification
Categories:
A61K 9/107, A61K 9/48, A61K 31/4709, A61P 7/10
Annual fees
Number
Paid
Expires
Payer
Number: 3
Paid: 15.8.2024
Expires: 4.8.2025
Payer: Árnason Faktor ehf.
Number: 4
Paid: 15.8.2025
Expires: 4.8.2026
Payer: Árnason Faktor ehf.